TABLE 5.
Group assignment* | Pre-STRIDE, %† | STRIDE, %† | p value‡ | Post-STRIDE, %† | p value‡ |
---|---|---|---|---|---|
Iron status information only | 5.0 | 5.2 | 0.58 | 3.8 | 0.63 |
No information or treatment | 5.1 | 10.7 | 0.0004 | 4.9 | 0.80 |
Iron 38 mg × 60 days | 5.2 | 3.1 | 0.09 | 9.4 | 0.03 |
Iron 19 mg × 60days | 5.1 | 3.2 | 0.06 | 7.5 | 0.07 |
Placebo × 60 days | 3.7 | 8.3 | 0.0006 | 4.8 | 0.42 |
Test for differences across group assignments§ | p = 0.73 | p = 0.0002 | p = 0.59 |
All donors are included. Group assignments are specified in Fig. 1.
The deferral rate was calculated as: # of hemoglobin deferrals % (# of deferrals + successful and quantity-not-sufficient donations).
Test for change from pre-STRIDE from repeated measures model (see Materials and Methods).
Test for common differences among group assignments from repeated measures model (see Materials and Methods).